Did I miss something? what exactly would she be taking to trial? they haven't created a chemical that affects / controls the gene they have identified.Scientists said S1PR2 could work by helping to make the blood-brain barrier, in charge of stopping potentially harmful substances from entering the brain and spinal fluid, more permeable.
A more permeable barrier could let attacking cells, which cause MS, into the central nervous system, the study said.
Prof Robyn Klein, of the Washington University School of Medicine, said: "We were very excited to find the molecule, as we wanted to find a target for treatment that didn't involve targeting the immune cells.
She would be looking at taking her findings to clinical trials in the "next few years", she added.
Users browsing this forum: No registered users